You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DYN Sale Disclosure
Rhodes Jason P · SEC Form 4 · Filed Jul 8, 2026
Sale
Calculated transaction value
$2.28M
Rhodes Jason P Director
DYN
Transaction date
Jul 6, 2026
Public filing date
Jul 8, 2026
Filing lag
Filed 2 days later
DYN daily price context
Close on/before transaction
$22.84
Jul 6, 2026
First close after public filing
$24.27
Jul 9, 2026
30-day return after filing
+8.16%
Through Aug 7, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 100,019 shares @ $22.79
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001577014-26-000014
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$17.86M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dyne Therapeutics, Inc. DYN | Sale | Jul 7, 2026 | $275.53K |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 7, 2026 | $350.62K |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 7, 2026 | $1.14M |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 7, 2026 | $118.05K |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 7, 2026 | $2.88M |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 7, 2026 | $698.84K |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 7, 2026 | $1.45M |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 6, 2026 | $5.77M |
| Dyne Therapeutics, Inc. DYN | Sale | Jul 6, 2026 | $2.9M |
| Dyne Therapeutics, Inc. DYN Current | Sale | Jul 6, 2026 | $2.28M |